Marathon Pharmaceuticals to charge $89000 for muscular dystrophy drug after 70-fold increase – Fox News


Fox News
Marathon Pharmaceuticals to charge $89000 for muscular dystrophy drug after 70-fold increase
Fox News
A drug to treat muscular dystrophy will hit the U.S. market with a price tag of $89,000 a year despite being available for decades in Europe at a fraction of that cost. Marathon Pharmaceuticals LLC’s pricing of the drug, which has been available in
Why Did That Drug Price Increase 6000%? It’s The LawForbes
Marathon Pharmaceuticals‘ Duchenne muscular dystrophy drug wins FDA approvalPharmaceutical Business Review
FDA approves drug to treat Duchenne muscular dystrophyFDA.gov
Wall Street Journal -Washington Post
all 68 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd